News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Daily News Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy Yael L. Maxwell June 08, 2018
News Conference News EuroPCR 2018 Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel Yael L. Maxwell May 30, 2018
News Daily News One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI Michael O'Riordan May 21, 2018
Presentation Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016 May 21, 2018
News Conference News SCAI 2018 Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI Todd Neale April 27, 2018
News Daily News Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib Todd Neale April 24, 2018
News Daily News Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI Yael L. Maxwell April 04, 2018
News Conference News ACC 2018 PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats Yael L. Maxwell March 14, 2018
News Conference News ACC 2018 Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS Caitlin E. Cox March 11, 2018
News Conference News ACC 2018 ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
Podcast TCTMD Talking Points Switching Antiplatelet Therapy: New International Consensus January 24, 2018
News Daily News De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP Yael L. Maxwell January 04, 2018
News Daily News Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis L.A. McKeown December 20, 2017
News Daily News Radial Access Best for PCI Following Thrombolysis in STEMI Michael O'Riordan November 27, 2017
News Conference News AHA 2017 RE-DUAL PCI Findings Consistent Across Key Subgroups Todd Neale November 16, 2017
News Conference News AHA 2017 GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS Yael L. Maxwell November 14, 2017
News Conference News AHA 2017 DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy Yael L. Maxwell November 12, 2017
News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017